Medical Health Cluster

Vaccines

Khosta-2, nuevo virus peligroso bastante similar al SARS-CoV-2

El nuevo virus forma parte de los Sarbecovirus, que es un subgénero del Betacoronavirus a los que pertenecen los Coronavirus. El patógeno bautizado como Khosta-2 tiene la capacidad para entrar en las células humanas y podría ser resistente a las vacunas actuales. La investigación científica sobre el hallazgo fue publicada […]

Read More

Despite Its Fan Base, Newly Authorized “Traditional” Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US

To say that Krystal Lashley went to great lengths to get the Novavax COVID-19 vaccine (NVX-CoV2373) would be a gross understatement. In April, Lashley traveled roughly 3700 miles from her home in Metuchen, New Jersey, to a pharmacy in Paris, France, for her first dose. She then flew to the […]

Read More

Resistance to recognizing airborne transmission of SARS-CoV-2 may be rooted in historical error

In a recent study published in Indoor Air, researchers extensively searched for the origins of the resistance to recognizing airborne transmission during the coronavirus disease 2019 (COVID-19) pandemic by major public health organizations, including the World Health Organization (WHO) and the United States Centers of Disease Control and Prevention (US-CDC). Background […]

Read More

Clinical management of COVID-19: Living guideline, 15 September 2022

The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important. The latest version of this living guideline is available in pdf format (via the ‘Download’ […]

Read More

Mantenerse al día con las vacunas contra el COVID-19, incluidas las dosis de refuerzo

Lo que necesita saber Los CDC recomiendan que todas las personas mantengan al día su vacunación contra el COVID-19, incluidas todas las dosis del esquema principal y las dosis de refuerzo correspondientes a su grupo de edad: Las personas de 6 meses a 4 años deben recibir todas las dosis del esquema […]

Read More

Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in China

Question  What are the 2-year health outcomes among patients hospitalized for COVID-19 in China? Findings  In this longitudinal cohort study that included 1864 patients, the most common symptoms at 2 years after SARS-CoV-2 infection were fatigue, chest tightness, anxiety, dyspnea, and myalgia, and most symptoms resolved from 1-year to 2-year follow-up, although […]

Read More

Encuentros sociales y sexuales más seguros y la viruela símica o del mono

Mientras los CDC trabajan para contener el brote de viruela símica actual y aprender más acerca del virus, esta información puede ayudarle a tomar decisiones fundamentadas cuando esté en situaciones o lugares donde pueda propagarse la viruela símica o del mono. La viruela símica o del mono suele transmitirse a […]

Read More

Severe Parechovirus Cases Among Infants Prompt CDC Warning

Clinicians should test for parechovirus in young infants with fever, sepsis-like symptoms, or meningitis without another known cause, according to a July 12 CDC health advisory sparked by reports of the illness in several states. Most children have been exposed to parechovirus by kindergarten. Symptoms may vary depending on the strain and […]

Read More